Mayo Spinout OneOme Raises $1M

May 20, 2015

|

NEW YORK (GenomeWeb) – Next-generation sequencing data firm OneOme has raised $1 million toward a targeted $5 million private financing round, it said in a document filed with the US Securities and Exchange Commission this week.

The company said 15 investors had participated in the round but did not disclose their identities. OneOme CEO Troy Kopischke told GenomeWeb that the financing is the firm's first seed round and will help it accelerate the growth of its pharmacogenomics platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Refined Risk Prediction

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

Shutdown and the FDA

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

This Week in PNAS

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

Influences from Here and There

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.

Main menu